Literature DB >> 7820295

Generalizations and applications of frailty models for survival and event data.

A Pickles1, R Crouchley.   

Abstract

A variety of survival models with both discrete and continuously distributed frailty is considered within a framework that involves the specification of three sub-models. An intensity sub-model specifies how the intensity is related to values of covariates and frailty; a measurement sub-model specifies how fallible measures of frailty are related to it; and an exposure sub-model specifies how frailty is distributed within the population. The models include those in which frailty is due to omitted covariates and those where it represents a covariate that has been measured subject to error. Multivariate frailty is also considered, with particular emphasis on models suitable for application to genetically related individuals, notably twins. A numerical example illustrates the use of a model with multivariate frailty for data on repeated exercise times.

Mesh:

Substances:

Year:  1994        PMID: 7820295     DOI: 10.1177/096228029400300305

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  5 in total

1.  Dynamic random effects models for times between repeated events.

Authors:  D Y Fong; K F Lam; J F Lawless; Y W Lee
Journal:  Lifetime Data Anal       Date:  2001-12       Impact factor: 1.588

2.  Modeling two-state disease processes with random effects.

Authors:  E T Ng; R J Cook
Journal:  Lifetime Data Anal       Date:  1997       Impact factor: 1.588

3.  Modelling conditional distributions in bivariate survival.

Authors:  R Henderson
Journal:  Lifetime Data Anal       Date:  1996       Impact factor: 1.588

4.  A bivariate survival model with compound Poisson frailty.

Authors:  A Wienke; S Ripatti; J Palmgren; A Yashin
Journal:  Stat Med       Date:  2010-01-30       Impact factor: 2.373

5.  Cure rate following rejection in bilateral corneal grafts for keratoconus.

Authors:  Mitra Rahimzadeh; Ebrahim Hajizadeh; Sepehr Feizi
Journal:  J Ophthalmic Vis Res       Date:  2010-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.